BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12975732)

  • 21. Interferon-induced depression: strategies in treatment.
    Asnis GM; De La Garza R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):808-18. PubMed ID: 15907352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotransmitter changes by interferon-alpha and therapeutic implications.
    Schaefer M; Schwaiger M; Pich M; Lieb K; Heinz A
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S203-6. PubMed ID: 14677080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-induced depression: a role for NSAIDs.
    Asnis GM; De La Garza R; Kohn SR; Reinus JF; Henderson M; Shah J
    Psychopharmacol Bull; 2003; 37(3):29-50. PubMed ID: 14608239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric side effects of interferon-alfa therapy.
    Van Gool AR; Kruit WH; Engels FK; Stoter G; Bannink M; Eggermont AM
    Pharm World Sci; 2003 Feb; 25(1):11-20. PubMed ID: 12661471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential mechanisms of interferon neurotoxicity.
    Bender CM; Monti EJ; Kerr ME
    Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions.
    Trask PC; Esper P; Riba M; Redman B
    J Clin Oncol; 2000 Jun; 18(11):2316-26. PubMed ID: 10829053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.
    Zahiu CD; Rimbas M
    Maedica (Bucur); 2014 Jun; 9(2):121-6. PubMed ID: 25705266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychiatric and neurological side effects of pharmaceutical preparations].
    Yamamoto N; Inada T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():131-6. PubMed ID: 18074528
    [No Abstract]   [Full Text] [Related]  

  • 30. Withdrawing interferon-α from psychiatric patients: clinical care or unjustifiable stigma?
    Spennati A; Pariante CM
    Psychol Med; 2013 Jun; 43(6):1127-32. PubMed ID: 22975198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiepileptics--a review of side effects during the last 11 years].
    Lakartidningen; 1982 Jul; 79(28-29):2646-50. PubMed ID: 7144348
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychiatric side-effects of interferon alfa therapy for hepatitis C and their management: a review.
    Al-Huthail YR
    Saudi J Gastroenterol; 2006; 12(2):59-67. PubMed ID: 19858587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lexinor--a 3-year follow-up. A certain risk for neurologic and psychologic adverse effects].
    Lakartidningen; 1989 Oct; 86(42):3577-8, 3583. PubMed ID: 2811516
    [No Abstract]   [Full Text] [Related]  

  • 34. [Psychiatric side effects of frequently used nonpsychiatric drugs].
    Vecht-van den Bergh R
    Ned Tijdschr Geneeskd; 1983 Dec; 127(51):2340-6. PubMed ID: 6656933
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurotoxicity of interferon-alpha.
    Merimsky O; Chaitchik S
    Anticancer Drugs; 1992 Dec; 3(6):567-70. PubMed ID: 1288726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions.
    Stasi C; Rosselli M; Zignego AL; Laffi G; Milani S
    Hepatol Res; 2014 Jan; 44(1):9-16. PubMed ID: 23607322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuropsychic complications of drugs in the elderly subject].
    Decamps A; Dumas R; Dordain G; Lavarenne J
    Therapie; 1984; 39(1):39-46. PubMed ID: 6463942
    [No Abstract]   [Full Text] [Related]  

  • 38. [On unilateral hyperpathic reactions in some neuro-psychiatric diseases in adults and children].
    Volkov AA
    Vopr Psikhiatr Nevropatol; 1965; 11():238-44. PubMed ID: 5883061
    [No Abstract]   [Full Text] [Related]  

  • 39. "On nervous disease in Thailand".
    Allison RS
    Ulster Med J; 1965 Dec; 34(2):74-92. PubMed ID: 5882079
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergy among the neuro-specialists.
    Agarwal SP
    Neurol India; 2006 Mar; 54(1):13-5. PubMed ID: 16679636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.